DNAJB6P8

Across TCGA pan-cancer cohorts, DNAJB6P8 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated DNAJB6P8 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher DNAJB6P8 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated DNAJB6P8 expression acts as an unfavorable survival marker, although some lineages such as UCS and ESCA show a favorable association.

UCS, UCEC, and THCA are the cancer types where DNAJB6P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Median	II,III,IV	0.576	0.220	.003	58	view →
UCEC	DFS	Tertile	III,IV	0.701	0.818	.024	48	view →
THCA	OS	Tertile	IV	0.478	0.939	<.001	48	view →
ESCA	DFS	Median	II,III,IV	1.000	0.303	.004	44	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	36	view →
ACC	DFS	Tertile	All	0.266	0.680	.001	36	view →
LUSC	DFS	Median	All	0.708	0.798	.006	18	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	18	view →
SARC	OS	Tertile	All	0.695	0.871	<.001	18	view →
KIRP	OS	Tertile	IV	0.037	0.429	.017	18	view →
KIRC	DFS	Median	All	0.519	0.698	.014	13	view →
PRAD	OS	Tertile	All	0.982	0.998	.001	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

DNAJB6P8–UCS (DFS)

Open the UCS breakdown →